(Total Views: 514)
Posted On: 04/21/2021 3:50:06 PM
Post# of 72440
Re: bettingbig #69332
Individuals who administer the IV do not know which IV contains B.
Individuals who draw blood do not know which patients are on Arm A or B.
Labs who analyze blood samples do not know from which patient samples were drawn.
Results of the blood analysis are not presented to hospital staff.
Testing Sites are designed and selected for all these reasons. Testing is difficult and expensive for all these reasons. CROs earn large fees for ensuring uncompromised results.
There are multiple procedures to mask patients and treatment arms.
Nobody knows who is taking Brilacidin. That is the entire purpose of blinded clinical study.
Any conclusions drawn are conjecture.
This article, indirectly, illustrate the challenge of anecdotal versus controlled analysis of efficacy. https://www.nytimes.com/2021/04/17/health/cov...e=Homepage
Individuals who draw blood do not know which patients are on Arm A or B.
Labs who analyze blood samples do not know from which patient samples were drawn.
Results of the blood analysis are not presented to hospital staff.
Testing Sites are designed and selected for all these reasons. Testing is difficult and expensive for all these reasons. CROs earn large fees for ensuring uncompromised results.
There are multiple procedures to mask patients and treatment arms.
Nobody knows who is taking Brilacidin. That is the entire purpose of blinded clinical study.
Any conclusions drawn are conjecture.
This article, indirectly, illustrate the challenge of anecdotal versus controlled analysis of efficacy. https://www.nytimes.com/2021/04/17/health/cov...e=Homepage
(0)
(0)Scroll down for more posts ▼
